| CRH | Corticotropin Releasing Hormone |
|---|---|
| FSH | 1) Follicle(Follicular)-Stimulating Hormone [HP 1884, 1891, 1902-3, 2010, 2017-21, 2031]... |
| GH | Growth Hormone = Somatotropin |
| GH-V | variant form of Growth Hormone |
| GnRH | Gonadotropin Releasing Hormone [HP 1898, 2034] = LHRH = Go... |
| placental growth hormone | human placental lactogen |
|---|---|
| msh release-inhibiting hormone | <chemical> An oligopeptide hormone produced in the hypothalamus that inhibits the release of melanocyte-stimulating hormone (msh). Chemical name: Melanostatin (12 Dec 1998) |
| msh-releasing hormone | A polypeptide hormone which originates in the hypothalamus and stimulates secretion of melanocyte-stimulating hormones in the pituitary gland. (12 Dec 1998) |
| corticotropic hormone | The hormone of the anterior lobe of the hypophysis which governs the nutrition and growth of the adrenal cortex, stimulates it to functional activity, and also possesses extraadrenal adipokinetic activity; it is a polypeptide containing 39 amino acids, but exact structure varies from one species to another; sometimes prefixed by a to distinguish it from beta-corticotropin. The first thirteen amino acids at the N-terminal region are identical to alpha-melanotropin. Synonym: adrenocorticotropin, adrenotropic hormone, adrenotropin, corticotropic hormone, corticotropin. (05 Mar 2000) |
| corticotropin-releasing hormone | <endocrinology, physiology> A neuropeptide released by the hypothalamus that stimulates the release of corticotropin by the anterior pituitary gland. Chemical name: Corticotropin-releasing factor Synonym: corticoliberin, corticotropin releasing factor. (12 Dec 1998) |
| pregnancy hormone | <biochemistry, gynaecology> Produced in the corpus luteum, as an antagonist of oestrogens. Promotes proliferation of uterine mucosa and the implantation of the blastocyst, prevents further follicular development. (18 Nov 1997) |
| heart hormone | A substance present in extracts of cardiac tissue that augments cardiac contraction; possibly adenosine, a catecholamine, or some non-specific stimulant present generally in tissues. Synonym: cardiac hormone, heart hormone. (05 Mar 2000) |
| salivary gland hormone | <chemical> Chemical name: Parotin (12 Dec 1998) |
| progestational hormone | <biochemistry, gynaecology> Produced in the corpus luteum, as an antagonist of oestrogens. Promotes proliferation of uterine mucosa and the implantation of the blastocyst, prevents further follicular development. (18 Nov 1997) |
| prolactin-inhibiting hormone | A substance of hypothalamic origin capable of inhibiting the synthesis and release of prolactin. Synonym: prolactin-inhibiting factor, prolactin-inhibiting hormone. Origin: prolactin + G. Stasis, standing still, + -in (05 Mar 2000) |
| prolactin release-inhibiting hormone | <chemical> A polypeptide hormone produced in the hypothalamus that inhibits the release of prolactin. Chemical name: Prolactin release-inhibiting factor (12 Dec 1998) |
| prolactin-releasing hormone | A polypeptide hormone that originates in the hypothalamus and stimulates the secretion of prolactin in the pituitary gland. (12 Dec 1998) |
| proparathyroid hormone | The immediate precursor of parathyroid hormone; proparathyroid differs from parathyroid hormone by an N-terminal hexapeptide extension. (05 Mar 2000) |
| herz hormone | A substance present in extracts of cardiac tissue that augments cardiac contraction; possibly adenosine, a catecholamine, or some non-specific stimulant present generally in tissues. Synonym: cardiac hormone, heart hormone. (05 Mar 2000) |
| hormone | <endocrinology> A naturally occuring substance secreted by specialised cells that affects the metabolism or behaviour of other cells possessing functional receptors for the hormone. Hormones may be hydrophilic, like insulin, in which case the receptors are on the cell surface or lipophilic, like the steroids, where the receptor can be intracellular. Some cancers may be stimulated and others inhibited by hormones (for example breast and prostate cancer). Some hormones can be synthesised and used as replacement in glandular deficiencies or as treatment for some cancers. Hormones may be injected, others taken by mouth. (29 Sep 1997) |